Apyx Medical Corporation
Apyx Medical Corporation（APYX）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · APYX · 截至 2025年9月30日
股东结构概览
50
机构持有人数
▲ 9 vs Q2
$33.67M
机构持仓总市值
▼ $1.90M vs Q2
41.87M
总流通股
freeFloat 86.73%
15.74M
13F 申报持股数
▼ 74,064 vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
APYX 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
NANTAHALA CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 3.34M | 8.20% | 8.20% | $7.14B | Nov 14, 2025 | — held |
ARCHON CAPITAL MANAGEMENT LLC surgical & medical instruments & apparatus | 3.28M | 8.06% | 8.06% | $7.02B | Nov 14, 2025 | — held |
ROYCE & ASSOCIATES LP surgical & medical instruments & apparatus | 2.47M | 6.08% | 6.08% | $5.30B | Nov 12, 2025 | ▲ 34.7K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 1.53M | 3.75% | 3.75% | $3.27B | Nov 7, 2025 | ▲ 53.2K |
SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC surgical & medical instruments & apparatus | 986.5K | 2.42% | 2.42% | $2.11B | Oct 7, 2025 | ▲ 89.8K |
COMMONWEALTH EQUITY SERVICES, LLC surgical & medical instruments & apparatus | 663.5K | 1.63% | 1.63% | $1.42B | Oct 22, 2025 | — held |
HORIZON KINETICS ASSET MANAGEMENT LLC surgical & medical instruments & apparatus | 615.0K | 1.51% | 1.51% | $1.32B | Nov 14, 2025 | — held |
BLACKROCK, INC. surgical & medical instruments & apparatus | 509.8K | 1.25% | 1.25% | $1.09B | Nov 12, 2025 | ▲ 6.8K |
TAYLOR FRIGON CAPITAL MANAGEMENT LLC surgical & medical instruments & apparatus | 470.7K | 1.16% | 1.16% | $1.01B | Oct 21, 2025 | ▼ 8.3K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 351.3K | 86.25% | 86.25% | $751.92M | Nov 12, 2025 | ▲ 1.6K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
14
增持
+310.2K 股10
新建仓
首次建仓9
减持
−456.4K 股0
清仓
完全退出净股数变化（前50家）
146.2K
+310.2K / −456.4K
净新增持仓人
+15
新建 10 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
APYX 内幕交易记录
数据来源：SEC Form 4
近期内部人员净买入。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
2
买入笔数
2
卖出笔数
1.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
HILL MATTHEW C Chief Financial Officer | May 15, 2025 | Award | 100,000 | $1.48 | $148.0K | 100.0K | Form 4 ↗ |
CITRONOWICZ MOSHE Sr. V.P. of Operations | May 15, 2025 | Award | 36,000 | $1.48 | $53.3K | 36.0K | Form 4 ↗ |
Waldman Lawrence director | May 15, 2025 | Award | 30,000 | $1.48 | $44.4K | 30.0K | Form 4 ↗ |
Baylor-Henry Minnie director | May 15, 2025 | Award | 59,000 | $1.48 | $87.3K | 59.0K | Form 4 ↗ |
Vizirgianakis Stavros G. director | May 15, 2025 | Award | 128,000 | $1.48 | $189.4K | 128.0K | Form 4 ↗ |
Goodwin Charles D. II Chief Executive Officer | May 15, 2025 | Award | 193,000 | $1.48 | $285.6K | 193.0K | Form 4 ↗ |
Levine Wendy Lauren director | May 15, 2025 | Award | 64,000 | $1.48 | $94.7K | 64.0K | Form 4 ↗ |
HILL MATTHEW C Chief Financial Officer | Aug 13, 2024 | Purchase | 6,000 | $1.13 | $6.8K | 8.5K | Form 4 ↗ |
Roman Shawn David Chief Operating Officer | Jan 15, 2025 | Award | 100,000 | $1.42 | $142.0K | 100.0K | Form 4 ↗ |
Goodwin Charles D. II Chief Executive Officer | Jan 15, 2025 | Award | 50,000 | $1.42 | $71.0K | 50.0K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Apyx Medical Corporation（APYX）主要由机构投资者持有，机构持股比例约为 37.6%。公司内部人员持股约 13.27%，散户及公众持股约占剩余的 49.15%。
Apyx Medical Corporation 最大机构股东为 NANTAHALA CAPITAL MANAGEMENT, LLC，截至 September 30, 2025 持有约 3.34 million 股，占总流通股的 8.20%。
目前共有 50 家机构持有 APYX 股票，合计持仓市值约 $33,674,427，数据来源为最新 SEC 13F 申报。
常见问题
APYX ownershipApyx Medical Corporation（APYX）主要由机构投资者持有，机构持股约 37.6%。最大股东为 NANTAHALA CAPITAL MANAGEMENT, LLC，持股比例 8.20%。内部人员持股约 13.27%。数据来源 SEC Form 13F，截至 September 30, 2025。